Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Liked2Thinkon Dec 08, 2020 5:40pm
158 Views
Post# 32063447

RE:RE:Brighter days on the horizon.

RE:RE:Brighter days on the horizon. In reality in the short run we will see it fall further is my guess.  End of year selling might hit us very bad.  There wont be any news for the rest of the year and the just sitting and waiting is always bad for a december month.  

if revenue ends up being 1.5M for Q4 I will take that as a win as I think testing for travel will slow down.  However January it might shoot way up again and make up for the xmas cool down.

I dont want to be a downer but facts is facts.  Im not selling and wont sell anytime soon, but this stock will not move past a dollar until big news about aristotle is released which I dont think will happen until Q2-Q3.

Lost of great news and great things said in that CC but fact is no one cares.  We are once again left hoping and guessing of how things will go with 0 guarentee of any of it.  It comes down do you have faith in Tripp and this company or do you not.
<< Previous
Bullboard Posts
Next >>